Meritage Homes Corporation (NYSE:MTH) shares moved up 2.42% in last trading session and ended the day at $39.29. MTH Gross Margin is 12.20% and its has a return on assets of 5.30%. Meritage Homes Corporation (NYSE:MTH) quarterly performance is -17.32%.
Meritage Homes Corporation (NYSE:MTH), a leading U.S. homebuilder, plans to release the Company’s third quarter 2015 results on Thursday, October 29, 2015 before the market opens. Following the release, management will host a conference call to discuss their results at 8:00 a.m. Arizona Time (10:00 a.m. Eastern Time).
NOW Inc. (NYSE:DNOW) ended the last trading day at $17.40. Company weekly volatility is calculated as 3.10% and price to cash ratio as 16.36. NOW Inc. (NYSE:DNOW) showed a weekly performance of -2.36%.
NOW Inc. (NYSE:DNOW) has scheduled a conference call to discuss the results for the third quarter of 2015 on Tuesday, November 3, 2015 at 8:00 am (US Central Time). Financial results for the third quarter of 2015 are expected to be released that morning before the market opens.
On 15 October, StarTek, Inc. (NYSE:SRT) shares moved up 6.39% and was closed at $4.66. SRT EPS growth in last 5 year was 8.40%. StarTek, Inc. (NYSE:SRT) year to date (YTD) performance is -52.21%.
On 7 October, StarTek Inc. (NYSE:SRT) said it will immediately hire 300 temporary employees for its Colorado Springs call center. The expansion follows a deal it signed with a global information services client. According to The Gazette, StarTek has signed more than 20 new clients in the past 18 months to contracts with an annual value of more than $60 million.
Real Goods Solar, Inc. (NASDAQ:RGSE) shares moved up 9.22% in last trading session and ended the day at $1.54. RGSE Gross Margin is 14.00% and its has a return on assets of -59.90%. Real Goods Solar, Inc. (NASDAQ:RGSE) quarterly performance is 2.67%.
Mast Therapeutics, Inc. (NYSEMKT:MSTX) caters to the Healthcare space. On the last day of trading company shares ended up at $0.51. Mast Therapeutics, Inc. (NYSEMKT:MSTX) distance from 50-day simple moving average (SMA50) is 9.58%.
BASF Corporation (BASF) and Mast Therapeutics, Inc. (NYSE MKT: MSTX) have agreed to collaborate in the development of a higher purity poloxamer 188. Currently, excipient-grade poloxamer 188 NF, marketed by BASF under the Kolliphor® P188 brand, is a polymer used in a variety of pharmaceutical and biological applications, such as a shear protectant in cell culture production. Poloxamer 188 is the starting material for Mast’s lead product candidate. Under the agreement between BASF and Mast, BASF will develop a higher purity poloxamer 188 and provide Mast with clinical quantities of the new material to be used for specific therapeutic indications.
Leave a Reply